A Pfizer vaccine trial participant said ‘let’s roll,’ pressing for the FDA to greenlight the first coronavirus shot course

A Pfizer vaccine trial participant said ‘let’s roll,’ pressing for the FDA to greenlight the first coronavirus shot course

Oil markets surged in the hours after Pfizer announced positive results from its coronavirus vaccine study.







Dado Ruvic/Reuters













The FDA's Vaccines and Related Biological Products Advisory Committee is meeting to discuss Pfizer's COVID-19 vaccine.

During the meeting, one person who was part of Pfizer's study said he believes the vaccine should receive emergency use authorization immediately to help save lives during the pandemic. 

Evan Fein got his first of two Pfizer shots on July 1 and said he's experienced no long-term side effects.

He did feel "mild" effects after his injections, he said, including a fever, chills, and pain where his second shot dose was administered.

"I understand the concerns about whether or not people will trust the vaccines, but there will always be some holdouts," Fein said during the hearing. "Most Americans will take the vaccine voluntarily, as long as we're honest, don't talk down to them, and treat them like autonomous adults."

For more stories like this, sign up here for Business Insider's daily healthcare newsletter.

Evan Fein can't know for sure, but he is pretty certain he got Pfizer's experimental coronavirus vaccine about five